|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.683
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.565
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.404
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.376
|
|
|
|
phosphatidylethanolamine biosynthetic process
|
GO:0006646 |
2 |
0.363
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.331
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.287
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.276
|
Human |
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.263
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.249
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.231
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.229
|
Human |
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.190
|
|
|
|
icosanoid biosynthetic process
|
GO:0046456 |
15 |
0.189
|
Human |
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.185
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.184
|
Human |
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.171
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.160
|
Human |
|
|
organic acid transport
|
GO:0015849 |
101 |
0.157
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.156
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.154
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.152
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.146
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.146
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.141
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.137
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.134
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.129
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.129
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.127
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.126
|
|
|
|
lipoxin a4 biosynthetic process
|
GO:2001303 |
1 |
0.125
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.124
|
Human |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.121
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.119
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.112
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.111
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.111
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.110
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.110
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.108
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.107
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.107
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.103
|
Human |
|
|
wound healing
|
GO:0042060 |
157 |
0.103
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.103
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.103
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.101
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.099
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.098
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.098
|
Human |
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.097
|
|
|
|
phosphatidylethanolamine metabolic process
|
GO:0046337 |
2 |
0.097
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.093
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.090
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.090
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.089
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.089
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.088
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.088
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.088
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.087
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.087
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.086
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.086
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.086
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.085
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.085
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.084
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.083
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.083
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.082
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.082
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.081
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.081
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.080
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.080
|
|
|
|
leukotriene biosynthetic process
|
GO:0019370 |
5 |
0.079
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.079
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.074
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.074
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.074
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.073
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.073
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.073
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.073
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.072
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.068
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.067
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.066
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.066
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.066
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.065
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.064
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.064
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.064
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.064
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.063
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.063
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.062
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.061
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.060
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.060
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.059
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.059
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.059
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.058
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.058
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.058
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.057
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.057
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.057
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.056
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.054
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.054
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.054
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.053
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.053
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.053
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.052
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.052
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.052
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.051
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.051
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.051
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.050
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.050
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.049
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.049
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.049
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.049
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.048
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.048
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.047
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.047
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.047
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.046
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.046
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.046
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.046
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.045
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.045
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.045
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.045
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.045
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.044
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.044
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.044
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.043
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.043
|
|
|
|
lipoxygenase pathway
|
GO:0019372 |
5 |
0.043
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.042
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.042
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.041
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.041
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.041
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.041
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.040
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.040
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.040
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.040
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.040
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.040
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.040
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.039
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.039
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.039
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.038
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.038
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.038
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.038
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.038
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.037
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.037
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.037
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.037
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.037
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.037
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.037
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.037
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.037
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.037
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.037
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.037
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.036
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.036
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.036
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.036
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.036
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.036
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.036
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.036
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.036
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.036
|
|
|
|
negative regulation of interleukin 10 secretion
|
GO:2001180 |
2 |
0.035
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.035
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.035
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.035
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.035
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.034
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.033
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.033
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.033
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.033
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.033
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.033
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.033
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.033
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.033
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.033
|
|
|
|
leukotriene metabolic process
|
GO:0006691 |
7 |
0.032
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.032
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.032
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.032
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.032
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.032
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.032
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.032
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.031
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.031
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.031
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.031
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.031
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.031
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.031
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.031
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.031
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.031
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.031
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.030
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.030
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.030
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.030
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.030
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.030
|
Human |
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.030
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.030
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.030
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.029
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.029
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.029
|
|
|
|
regulation of homotypic cell cell adhesion
|
GO:0034110 |
13 |
0.029
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.029
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.029
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.029
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.029
|
|
|
|
positive regulation of fever generation by positive regulation of prostaglandin secretion
|
GO:0071812 |
2 |
0.029
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.029
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.029
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.029
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.029
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.029
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.029
|
|
|
|
positive regulation of type 2 immune response
|
GO:0002830 |
9 |
0.029
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.028
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.028
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.028
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.028
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.028
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.028
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.028
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.028
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.028
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.028
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.027
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.027
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.027
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.027
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.027
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.027
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.027
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.027
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.027
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.027
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.027
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.027
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.027
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.027
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.027
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.027
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.026
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.026
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.026
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.026
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.026
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.026
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.026
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.025
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.025
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.025
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.025
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.025
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.025
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.025
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.025
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.025
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.024
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.024
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.024
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.024
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.024
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.024
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.024
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.024
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.024
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.023
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.023
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.023
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.023
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.023
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.023
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.023
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.023
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.023
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.023
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.023
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.023
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.023
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.023
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.023
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.023
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.023
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.022
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.022
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.022
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.022
|
|
|
|
circadian temperature homeostasis
|
GO:0060086 |
2 |
0.022
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.022
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.022
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.022
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.022
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.022
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.022
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.021
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.021
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.021
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.021
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.021
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.021
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.021
|
|
|
|
protein lipidation
|
GO:0006497 |
28 |
0.021
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.021
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.021
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.021
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.021
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.021
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.021
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.021
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.021
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.021
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.021
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.020
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.020
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.020
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.020
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.020
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.020
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.020
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.020
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.020
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.020
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.020
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.020
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.020
|
|
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
5 |
0.020
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.020
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.019
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.019
|
|
|
|
negative regulation of alpha beta t cell activation
|
GO:0046636 |
18 |
0.019
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.019
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.019
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.019
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.019
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.019
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.019
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.019
|
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.019
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.019
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.019
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.019
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.019
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.019
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.019
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.019
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.018
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.018
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.018
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.018
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.018
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.018
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.018
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.018
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.018
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.018
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.018
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.018
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.018
|
Zebrafish |
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.018
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.018
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.018
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.018
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.017
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.017
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.017
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.017
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.017
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.017
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.017
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.017
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.017
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.017
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.017
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.017
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.017
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.017
|
|
|
|
icosanoid secretion
|
GO:0032309 |
12 |
0.017
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.017
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.017
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.017
|
|
|
|
chemokine production
|
GO:0032602 |
34 |
0.017
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.017
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.017
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.017
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.017
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.017
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.017
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.017
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.017
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.017
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.017
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.017
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.017
|
|
|
|
positive regulation of killing of cells of other organism
|
GO:0051712 |
3 |
0.017
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.017
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.017
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.017
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.017
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.017
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.016
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.016
|
|
|
|
regulation of cytokine secretion involved in immune response
|
GO:0002739 |
4 |
0.016
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.016
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.016
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.016
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.016
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.016
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.016
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
39 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.016
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.016
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.016
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.016
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.016
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.016
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.016
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.016
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.016
|
|
